0000000001186823

AUTHOR

F. Eyskens

showing 1 related works from this author

An international, phase 3, switchover study of reveglucosidase alfa (BMN 701) in subjects with late-onset Pompe disease

2015

Pediatricsmedicine.medical_specialtyNeurologybusiness.industryPediatrics Perinatology and Child HealthSwitchoverMedicineLate onsetNeurology (clinical)DiseasebusinessGenetics (clinical)SurgeryNeuromuscular Disorders
researchProduct